B
Benoît Soubeyrand
Researcher at Sanofi Pasteur
Publications - 49
Citations - 1430
Benoît Soubeyrand is an academic researcher from Sanofi Pasteur. The author has contributed to research in topics: Vaccination & Tetanus. The author has an hindex of 18, co-authored 48 publications receiving 1336 citations.
Papers
More filters
Journal ArticleDOI
Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV).
François Aubin,Jean-Luc Prétet,Anne-Carole Jacquard,Maëlle Saunier,Xavier Carcopino,Fatiha Jaroud,Pierre Pradat,Benoît Soubeyrand,Yann Leocmach,Christiane Mougin,Didier Riethmuller +10 more
TL;DR: The results provide strong evidence that, in France, the most prevalent HPV genotypes in persons with EAC are 6 and 11, and the quadrivalent HPV vaccine could prevent 62%-87% of EAC cases in France.
Journal ArticleDOI
Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study
Laurent Abramowitz,Anne-Carole Jacquard,Fatiha Jaroud,Julie Haesebaert,Laurent Siproudhis,Pierre Pradat,Pierre Pradat,Olivier Aynaud,Yann Leocmach,Benoît Soubeyrand,Roger Dachez,Didier Riethmuller,Christiane Mougin,Jean-Luc Prétet,François Denis +14 more
TL;DR: It is indicated that anal cancer rarely occurs in the absence of HPV and emphasize the predominant role of HPV16, which is by far the most prevalent genotype.
Journal ArticleDOI
Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.
Jean Lacau St Guily,Anne-Carole Jacquard,Jean-Luc Prétet,Julie Haesebaert,Agnès Beby-Defaux,Christine Clavel,Gérard Agius,Philippe Birembaut,Claire Okaïs,Yann Leocmach,Benoît Soubeyrand,Pierre Pradat,Didier Riethmuller,Christiane Mougin,François Denis +14 more
TL;DR: The results indicate that HPV is common among oropharyngeal and oral cavity carcinoma cases in France and emphasize the predominance of HPV 16.
Journal ArticleDOI
Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study
Jean-Luc Prétet,Anne-Carole Jacquard,Xavier Carcopino,J. F. Charlot,Damien Bouhour,Bernadette Kantelip,Benoît Soubeyrand,Yann Leocmach,Christiane Mougin,Didier Riethmuller +9 more
TL;DR: Given the high HPV 16/18 prevalence and taking into account possible production of crossneutralizing antibodies against other HPV types, HPV 16 /18 L1 VLP vaccination would be expected to significantly reduce the burden of ICC in France.
Journal ArticleDOI
Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial.
Jean Beytout,Odile Launay,Nicole Guiso,Anne Fiquet,Martine Baudin,Patrick Richard,Charles Baptiste,Benoît Soubeyrand +7 more
TL;DR: Tdap-IPV may be administered to adults 1 month after vaccination with tetanus, diphtheria, inactivated poliovirus vaccination in healthy adults vaccinated according to the French vaccination calendar without exacerbating post-vaccination side-effects.